Answers are grounded in this paper and cite their sources.
Seventeen patients with disseminated malignant melanoma received a daily oral regimen of tamoxifen, 100 mg/m2. All patients had prior chemotherapy and predominantly visceral involvement. None of the patients had an objective regression and most (71%) had progressive disease at the time of first reassessment. Moderate to severe nausea occurred in 24% of patients. In the dose and schedule used in this study, tamoxifen is ineffective in patients with advanced malignant melanoma and prior chemotherapy exposure.
No takes yet. Share an insight, caveat, or question.
Creagan et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: